drugset / Trial / NCT02870764

The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris

NCT02870764 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled, adaptive clinical trial, which will assess the effect of DanshenDuofensuanyan\[Danshen (a kind of Chinese herbal drug) extract\] treatment on Lipoprotein associated phospholipase A2 level in patients with stable angina pectoris.

Timeline

Start
2016-09
Primary completion
2017-05
Completion
2017-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator DanshenDuofensuanyan Traditional medicine (herbal / TCM) 30 unknown Intravenous
Comparator DanshenDuofensuanyan Traditional medicine (herbal / TCM) 200 mg Intravenous